Literature DB >> 1881938

Prostaglandin release by normal and osteomyelitic human bones.

D Plotquin1, S Dekel, S Katz, A Danon.   

Abstract

The release of prostaglandin E (PGE) and prostacyclin (as 6-keto PGF1 alpha) by human osteomyelitic bone, compared with normal (control) bone, incubated in vitro was evaluated. Prostacyclin was the main arachidonic acid metabolite released by normal human bone, and similar quantities were released by osteomyelitic bone. However, PGE production was 5-30-fold higher in osteomyelitic bone, compared with control, thus becoming the major prostanoid in this disease. It is concluded that PGE production is probably involved in the inflammatory and/or bone resorption processes that occur in osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881938     DOI: 10.1016/0952-3278(91)90126-p

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  3 in total

1.  Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype.

Authors:  Y Sakuma; K Tanaka; M Suda; Y Komatsu; A Yasoda; M Miura; A Ozasa; S Narumiya; Y Sugimoto; A Ichikawa; F Ushikubi; K Nakao
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Long Bone Osteomyelitis.

Authors:  Luca Lazzarini; Fausto De Lalla; Jon T. Mader
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

3.  Osteocytes Serve as a Reservoir for Intracellular Persisting Staphylococcus aureus Due to the Lack of Defense Mechanisms.

Authors:  Marina Garcia-Moreno; Paul M Jordan; Kerstin Günther; Therese Dau; Christian Fritzsch; Monika Vermes; Astrid Schoppa; Anita Ignatius; Britt Wildemann; Oliver Werz; Bettina Löffler; Lorena Tuchscherr
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.